abstract |
(57) [Summary]nThe present invention relates to methods and pharmaceutical formulations for the treatment of autoimmune arthritis and its animal models in mammals, including humans, by oral, enteral, or inhalation administration of whole collagen protein or physiologically active peptide fragments of collagen. . |